Institutional investors purchased a net $2.2 million shares of GHDX during the quarter ended June 2014 and now own 90.54% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM BELGIUM SA Bought 34.0 Thousand shares of Genomic Health Inc